A recent study on locally advanced rectal cancer (LARC) suggests that pathologic complete response (pCR) after total neoadjuvant therapy (TNT) does not guarantee improved overall survival (OS). Although TNT increases pCR rates, patients achieving pCR through neoadjuvant chemoradiation (nCRT) alone demonstrated better OS. This finding underscores the prognostic significance of the treatment route in managing LARC. Therefore, clinicians should consider the neoadjuvant therapy pathway critically when planning treatment strategies. For comprehensive details, access the full study here: https://doi.org/10.1245/s10434-024-15469-5
The Prognostic Significance of Tumor Deposits in Gastric Cancer
A comprehensive multicenter study involving 781 patients with locally advanced gastric cancer (LAGC) revealed significant findings about tumor deposits (TDs). The study highlighted that TDs are associated with larger tumor size (≥ 5 cm) and vascular invasion. Independent risk factors for poor prognosis include TD positivity, tumor diameter, advanced pT4a stage, and vascular invasion. Particularly, patients with TDs at pT4a and pN3b stages exhibit notably lower 5-year overall and disease-free survival rates. These insights underscore the necessity of considering TDs in the prognosis and tailored management of LAGC. For further details, refer to the full study here: https://doi.org/10.1245/s10434-024-15508-1
Risk of Advanced Neoplasia and CRC Post Adenoma Removal with HGD
A study analyzed 814 patients who had colorectal adenomas with high-grade dysplasia (HGD) removed, revealing significant risks of advanced neoplasia (AN) and colorectal cancer (CRC). Over 2000 person-years of follow-up showed AN and CRC incidence densities of 44.3 and 4.4 per 1000 person-years, respectively. Synchronous polyps and elevated baseline carcinoembryonic antigen (CEA) levels were key risk factors. However, surveillance colonoscopies markedly reduced AN and CRC incidences. Patients with these risk factors need frequent monitoring to manage their long-term cancer risks effectively. Full study available at: https://doi.org/10.1007/s00464-024-10898-5
Comparing TEM and SP Robotic Platforms for Rectal Lesions
A study comparing transanal endoscopic microsurgery (TEM) and single-port robotic transanal minimally invasive surgery (SP rTAMIS) for rectal lesion excision found that SP rTAMIS offers shorter operative times and lower postoperative morbidity. Both methods had similar rates of positive margins and piecemeal resection, with no intraoperative complications in either cohort. SP rTAMIS had fewer postoperative complications (9% vs. 20%, p = 0.031) and no mortalities. These findings support SP robotics as a promising alternative to TEM for rectal lesion excision. Full study available at: https://doi.org/10.1007/s00464-024-10895-8
Robotic Pelvic Lymph Node Dissection in Advanced Rectal Cancer
A recent meta-analysis compared robotic pelvic lateral lymph node dissection (LPLND) to laparoscopic LPLND in patients with advanced rectal cancer. The study found that robotic surgery led to more pelvic lymph nodes being harvested and fewer complications, especially regarding urinary retention, despite longer operation times. This suggests potential advantages of robotic over laparoscopic techniques in this context. Further research is needed to strengthen these findings, but the results indicate that robotic surgery could be a valuable option in treating advanced rectal cancer. Full study available at: https://doi.org/10.1007/s00464-024-10901-z
Predictive Factors for Better Outcomes in Peritoneal Metastasis of Gastric Cancer
A new study has identified significant predictive factors for patients with peritoneal metastasis of gastric cancer (PMGC) who underwent aggressive treatment strategies. The study focused on patients who received a combination of cytoreductive surgery (C-CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) after responding to induction chemotherapy.
Key findings include:
Patients with a Ki-67 index lower than 10 had significantly better recurrence-free and overall survival.
Limited lymph node involvement (LNI < 2) and smaller omental lesion size (< 0.5 cm) were associated with improved outcomes.
The study retrospectively examined 62 patients and found that those with these favorable parameters had a higher likelihood of long-term survival. Cox regression analysis further confirmed that decreased Ki-67 expression and minimal lymph node involvement were independent factors for better prognosis.
These results underscore the importance of thorough preoperative assessment to identify patients who are likely to benefit most from an aggressive multimodal treatment approach. This approach includes initial induction chemotherapy, followed by surgery and HIPEC, and aims to maximize survival outcomes.
For detailed insights, read the full study here.